|
References
|
| |
|
Aalbers R, Backer V, Kava TTK, et al. Adjustable maintenance dosing with budesonide/formoterol compared with fixed dose salmeterol/fluticasone in moderate to severe asthma. Curr Med Res Opin 2004;20:225–240.
|
| |
|
Ankerst J, Persson G, Weibull E. Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma. Pulm Pharmacol Ther 2003;16:147–151.
|
| |
|
Balanag VM, Yunus F, Yang PC, et al. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Pulm Pharm Ther 2006;19:139–147.
|
| |
|
Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control Study. Am J Respir Crit Care Med 2004;170:836–844.
|
| |
|
Batement ED, et al. Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. Respir Res 2006;7:13.
|
| |
|
Bisgaard H, Le Roux P, Bjamer D, Dymek A, Vermeulen JH, Hultquist C. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest. 2006;130:1733–1743.
|
| |
|
Boonsawat W, et al. Formoterol (Oxis) Turbuhaler as a rescue therpay compared with salbutamol pMDI plus spacer in patients with acute severe asthma. Respir Med 2003;97:1067–1074.
|
| |
|
Briggs AH, Bousquet J, Wallace MV, et al. Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy 2006;61:531–536.
|
| |
|
Busse WW, Chervinsky P, Condemi J, et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 1998;101:457–463.
|
| |
|
Ernst P, et al. Safety and effectiveness of long-active inhaled b-agonist brinchodilators when taken with inhaled corticosteroids. Ann Intern Med 2006;145:692–694.
|
| |
|
Fitzgerald MJ, et al. Asthma exacerbations. 4: Prevention. Thorax 2006;61:992–999.Fitzgerald MJ, et al. Asthma exacerbations. 4: Prevention. Thorax 2006;61:992–999.
|
| |
|
Fitzgerald JM, Sears MR, Boulet LP, et al. Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: A five month multicentre Canadian study. Can Respir J 2003;10:427–434.
|
| |
|
Foresi A, et al. Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. Chest 2000;117:440–446.
|
| |
|
Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: NHLBI/WHO Workshop report, 2002; publication no 02-3659.
|
| |
|
Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention 2006. Available at www.ginasthma.org.
|
| |
|
Johansson G, et al. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. Pharamcoecoonomics 2006;24:695–708.
|
| |
|
Ketchell RI, Jensen MW, Spina D, et al. Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine. Eur Respir J 2002;19:611–616.
|
| |
|
Kips JC, O'Connor BJ, Inman MD, et al. A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Am J Respir Crit Care Med 2000;161:996–1001.
|
| |
|
Kuna P, Peters MJ, Manjra AI, et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations Int J Clin Pract 2007; (in press).
|
| |
|
O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164:1392–1397.
|
| |
|
O’Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005;171:129–136.
|
| |
|
Palmqvist M, Arvidsson P, Beckman O, et al. Onset of bronchodilatation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. Pulm Pharmacol Ther 2001;14:29–34.
|
| |
|
Partridge MR, van de Molen T, Myrseth SE, et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006;6:13.
|
| |
|
Pauwels RA, Löfdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. NEJM 1997;337:1405–1411.
|
| |
|
Pauwels R, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double blind trial. Lancet 2003;361:1071–1076.
|
| |
|
Price D, et al. Budesonide/formoterol (B/F) as maintenance and relief for asthma improves efficacy and is cost-saving versus a higher maintenance dose of B/F or salmeterol/fluticasone (S/F). Eur Respir J 2006;28(Suppl. 50):214s; Abstract.
|
| |
|
Rabe KF, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006a;368:744–753.
|
| |
|
Rabe KF, Pizzichini E, Stallberg B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest 2006b;129:246–256.
|
| |
|
Ringdal N, Derom E, Wåhlin-Boll E, et al. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler. Respir Med 1998;92:1017–1021.
|
| |
|
Rosenhall L, Borg S, Andersson F, et al. Budesonide/formoterol in a single inhaler (Symbicort®) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months. Int J Clin Pract 2003a;57:662–667.
|
| |
|
Rosenhall L, Elvstrand A, Tilling B, et al. One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort® Turbuhaler®) for the treatment of asthma. Respir Med 2003b;97:702–708.
|
| |
|
Scicchitano R, Aalbers R, Ukena D, et al. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin 2004;20:1403–1418.
|
| |
|
Seberova E, et al. Oxis (formoterol given by Turbuhaler) showed as rapid onset of action as salbutamol given by a pMDI. Respir Med 2000;94:607–611.
|
| |
|
Ställberg B, Olsson P, Jorgensen LA, et al. Budesonide/Formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing. Int J Clin Pract 2003;57:656–661.
|
| |
|
Sin DD, et al. Pharmacological management to reduce exacerbations in adults with asthma : a systematic review and meta-analysis. J Am Med Assoc 2004 ;292 :367–376.
|
| |
|
Tal A, Simon G, Vermeulen JH, et al. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Pediatr Pulmonol 2002;34:342–350.
|
| |
|
Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma - a descriptive study of 425 severe exacerbations. Am J Respir Crit Care Med 1999;160:594–599.
|
| |
|
Tötterman KJ, Huhti L, Sutinen E, et al. Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients. Eur Respir J 1998;12:573–579.
|
| |
|
Toogood JH, Baskerville JC, Jennings B, et al. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid budesonide. J Allergy Clin Immunol 1982;70:288–298.
|
| |
|
Van der Woude HJ, et al. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. Pulm Pharmacother 2004;17:89–95.
|
| |
|
Vogelmeier C, D’Urzo A, Pauwels R, et al. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J 2005;26:819–828.
|
| |
|
Zetterström O, Buhl R, Mellem H, et al. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J 2001;18:262–268.
|
| |
back to top 
|
